OTCM
ABTI
, Last price
USD
Name
Alterola Biotech Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
47.63%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
-2m
L-76.16%
CFO
-1m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.
Key people
Irving Aronson
Chairman of the Board · since 2019
Dheeraj Jain
Chief Operating Officer, Director · since 2019
Lalit Kumar
Chief Executive Officer, Director · since 2019
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑03 | 2022‑03 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||